
Redilife Pharmaceuticals Private Limited
Founded in 2020 and headquartered in Karnataka, India.
Founded in 2020 and headquartered in Karnataka, India.
Davangere, Karnataka, India
+91-XXXXXXXXXX
U24299KA2020PTC139105
139105
Private Limited Indian Non-Government Company
28 Sep 2020
-
-
Unlisted
Roc Bangalore
Name | Designation | Appointment Date | Status |
---|---|---|---|
Bannadanoolu Veeresh ![]() | Director | 28-Sep-2020 | Current |
Veena Kotur ![]() | Director | 28-Sep-2020 | Current |
Tadakanahalli Tanuja ![]() | Director | 28-Sep-2020 | Current |
Enhance accessibility to Redilife Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Redilife Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
There are no open charges registered against the company as per our records.
Redilife Pharmaceuticals has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Redilife Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Redilife Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Bannadanoolu Shambulingappa Veeresh was appointed as a Director was appointed as a Director on 28 Sep 2020 & has been associated with this company since 4 years 8 months .
Veena Kotur was appointed as a Director was appointed as a Director on 28 Sep 2020 & has been associated with this company since 4 years 8 months .
Tadakanahalli Doddamane Tanuja was appointed as a Director was appointed as a Director on 28 Sep 2020 & has been associated with this company since 4 years 8 months .
Redilife Pharmaceuticals Private Limited was registered on 28 Sep 2020 with Roc Bangalore & aged 4 years 8 months as per MCA records.
Redilife Pharmaceuticals Private Limited was incorporated on 28 Sep 2020.
The authorized share capital of Redilife Pharmaceuticals Private Limited is ₹ 1.50 M and paid-up capital is ₹ 0.10 M.
Currently 3 directors are associated with Redilife Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Redilife Pharmaceuticals Private Limited is 575 1St Main 10Th Cross Nijalingappa Badavane India, Davanagere, Karnataka, 577004.
The corporate identification number (CIN) of Redilife Pharmaceuticals Private Limited is U24299KA2020PTC139105 and the company number is 139105 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.